Pandox has completed its €1.7 billion acquisition of Dalata Hotel Group, strengthening its position as a major investor in the UK and Ireland’s hotel and real estate sectors. The transaction includes approximately €1.4 billion for the equity purchase and the assumption of around €300 million in Dalata’s net debt. The acquisition was carried out through Pandox Ireland Tuck Limited, with ownership split at roughly 91–92% for Pandox and 8–9% for Eiendomsspar.

The consortium made an all‑cash offer for all Dalata shares under a court‑sanctioned scheme of arrangement. The scheme became effective on 7 November 2025, resulting in Dalata’s delisting from both Euronext Dublin and the London Stock Exchange.

Pandox funded the acquisition through a financing package that included an acquisition facility of around €1.165 billion arranged by DNB and Carnegie, supported by existing credit facilities and cash resources. The financing facility begins with a margin of about 225 basis points above the reference rate, increasing by 25 basis points every nine months until its July 2027 maturity. Public documentation associated with the deal does not indicate any loan participation from AIB, and DNB and Carnegie are the only named lenders involved in the acquisition financing.

The completed acquisition adds scale to Pandox’s regional portfolio and brings Dalata’s substantial hotel assets into its growing operational platform. The transaction reflects continued investor activity within the UK and Ireland’s hospitality market and demonstrates sustained interest in hotel portfolios across key urban locations.